Oztürk Y, Altan V M, Yildizoğlu-Ari N
Department of Pharmacology, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
Pharmacol Toxicol. 1992 Oct;71(4):250-3. doi: 10.1111/j.1600-0773.1992.tb00978.x.
Recently, decreased gastrointestinal beta-adrenergic responses in experimental diabetes have been demonstrated. Gastrointestinal responses to beta-adrenoceptor agonists are impaired in both insulin-dependent and non-insulin-dependent diabetic rat. Insulin treatment improves the impaired gastrointestinal beta-adrenergic responsiveness of diabetic rats. The improvement seen with insulin treatment on beta-adrenergic responsiveness is closely related to protein biosynthesis. The decreased beta-adrenergic responses in diabetic rat gastrointestinal tract seem to result from a decrease in the number of beta-adrenoceptors. It is most likely that the decreased gastrointestinal beta-adrenergic responsiveness is related to an impairment in the turnover of beta-adrenoceptors as a consequence of diabetes and that insulin has a beneficial effect on the impaired receptor turnover.
最近,实验性糖尿病中胃肠道β-肾上腺素能反应降低已得到证实。在胰岛素依赖型和非胰岛素依赖型糖尿病大鼠中,胃肠道对β-肾上腺素能受体激动剂的反应均受损。胰岛素治疗可改善糖尿病大鼠受损的胃肠道β-肾上腺素能反应性。胰岛素治疗对β-肾上腺素能反应性的改善与蛋白质生物合成密切相关。糖尿病大鼠胃肠道中β-肾上腺素能反应降低似乎是由于β-肾上腺素能受体数量减少所致。很可能胃肠道β-肾上腺素能反应性降低与糖尿病导致的β-肾上腺素能受体周转受损有关,而胰岛素对受损的受体周转具有有益作用。